Agency Information Collection Activities; Proposed Collection; Comment Request; Testing Communications on the Food and Drug Administration/Center for Veterinary Medicine's Regulated Products Used in Animals, 51271-51272 [2010-20482]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 160 / Thursday, August 19, 2010 / Notices
51271
ESTIMATE OF ANNUALIZED BURDEN TABLE—Continued
Form
Number of
respondents
Number of
responses per
espondent
Average burden
per response
(hours)
..................................
............................
............................
............................
Respondent
Total burden
(in hours)
—Males (18+ yrs) at gay pride events
—Racial/ethnic minority males (18+ yrs) at
minority gay pride events
—African American males and females
(18–35 yrs) at spring break festivals
Total ....................................................
Dated: August 13, 2010.
Thelma Sims,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2010–20568 Filed 8–18–10; 8:45 am]
BILLING CODE 4163–18–P
FOR FURTHER INFORMATION CONTACT:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Denver Presley, Jr., Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., P150–
400B, Rockville, MD 20850, 301–796–
3793.
Food and Drug Administration
[Docket No. FDA–2010–N–0420]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Testing
Communications on the Food and
Drug Administration/Center for
Veterinary Medicine’s Regulated
Products Used in Animals
AGENCY:
Food and Drug Administration,
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
communication studies involving FDA/
Center for Veterinary Medicine (CVM)
regulated products intended for use in
animals. This information will be used
to explore concepts of interest and assist
in the development and modification of
communication messages and
campaigns to fulfill the Agency’s
mission in protecting the public health.
DATES: Submit either electronic or
written comments on the collection of
information by October 18, 2010.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
emcdonald on DSK2BSOYB1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:05 Aug 18, 2010
Jkt 220001
Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined in
44 U.S.C. 3502(3) and 5 CFR 1320.3(c)
and includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires Federal agencies
to provide a 60-day notice in the
Federal Register concerning each
proposed collection of information
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
SUPPLEMENTARY INFORMATION:
HHS.
ACTION:
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
1,633
when appropriate, and other forms of
information technology.
Testing Communications on the Food
and Drug Administration/Center for
Veterinary Medicine’s Regulated
Products Used in Animals—21 U.S.C.
393 (d)(2)(D)—(OMB Control Number–
0910–NEW )
CVM has authorization under section
903(d)(2)(D) of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C.
393(d)(2)(D) to conduct educational and
public information programs relating to
the safety of CVM-regulated products.
Further, CVM is authorized to conduct
this needed research to ensure that these
programs have the highest likelihood of
being effective. Thus, CVM concludes
that improving communications about
the safety of regulated animal drugs,
feed, food additives, and devices will
involve many research methods,
including individual indepth
interviews, mall-intercept interviews,
focus groups, self-administered surveys,
gatekeeper reviews, and omnibus
telephone surveys.
The information collected will serve
three major purposes. First, as formative
research, it will provide critical
knowledge needed about target
audiences to develop messages and
campaigns about the use of animal
drugs, feed, food additives, and devices.
Knowledge of both the consumer and
the veterinary professional
decisionmaking processes will provide a
better understanding of target audiences
that FDA will need in order to design
effective communication strategies,
messages, and labels. These
communications will aim to improve
public understanding of the risks and
benefits of using regulated animal drugs,
feed, food additives, and devices by
providing users with a better context in
which to place risk information more
completely. Second, as initial testing, it
will allow FDA to assess the potential
effectiveness of messages and materials
in reaching and successfully
communicating with their intended
audiences. Testing messages with a
sample of the target audience will allow
E:\FR\FM\19AUN1.SGM
19AUN1
51272
Federal Register / Vol. 75, No. 160 / Thursday, August 19, 2010 / Notices
FDA to refine messages while still in the
developmental stage. Respondents will
be asked to give their reaction to the
messages in either individual or group
settings. Third, as evaluative research, it
will allow FDA to ascertain the
effectiveness of the messages and the
distribution method of these messages
in achieving the objectives of the
message campaign. Evaluation of
campaigns is a vital link in continuous
improvement of communications at
FDA.
FDA estimates the burden of this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
No. of
Respondents
21 U.S.C. 393(d)(2)(D)
Annual Frequency
per Response
Total Annual
Responses
Hours per
Response
Total Hours
Individual indepth interviews
360
1
360
.75
270
General public focus group interviews
144
1
144
1.5
216
Intercept interviews: Central location
600
1
600
.25
150
10,000
1
10,000
.08
800
2,400
1
2,400
.25
600
400
1
400
.50
200
2,400
1
2,400
.17
408
Intercept Interviews: Telephone2
Self-administered surveys
Gatekeeper reviews
Omnibus surveys
Total (general public)
2,644
Total veterinarian/scientific expert focus
group interviews
144
1
144
Total Burden
1 There
2 These
1.5
216
2,860
are no capital costs or operating and maintenance costs associated with this collection of information.
are brief interviews with callers to test message concepts and strategies following their call-in request to an FDA Center 1–800
number.
FDA’s estimate for the annual
reporting burden of the proposed
collection of information requirements
is based on recent prior experience with
the various types of data collection
methods described previously. FDA
projects about 30 studies for which the
annual reporting burden is estimated to
be 2,860 hours.
Dated: August 13, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–20482 Filed 8–18–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
emcdonald on DSK2BSOYB1PROD with NOTICES
Proposed Collection; Comment
Request; STAR METRICS—Science
and Technology in America’s
Reinvestment: Measuring the Effects
of Research on Innovation,
Competitiveness and Science
In compliance with the
requirement of Section 3506(c)(2)(A) of
SUMMARY:
VerDate Mar<15>2010
17:05 Aug 18, 2010
Jkt 220001
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
Office of Science Policy Analysis
(OSPA), the National Institutes of
Health (NIH) will publish periodic
summaries of proposed projects to be
submitted to the Office of Management
and Budget (OMB) for review and
approval.
Proposed Collection: Title: STAR
METRICS—Science and Technology for
America’s Reinvestment: Measuring the
Effects of Research on Innovation,
Competitiveness and Science.
Type of Information Collection
Request: Extension.
Need and Use of Information
Collection: The aim of STAR METRICS
is twofold. The initial goal of STAR
METRICS is to provide mechanisms that
will allow participating universities and
Federal agencies with a reliable and
consistent means to account for the
number of scientists and staff that are on
research institution payrolls, supported
by Federal funds. In subsequent
generations of the program, it is hoped
that STAR METRICS will allow for
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
measurement of science impact on
economic outcomes (such as job
creation), on knowledge generation
(such as citations and patents) as well
as on social and health outcomes.
Frequency of Response: Quarterly.
Affected Public: Universities.
Type of Respondents: University
administrators.
Estimated Number of Respondents:
100.
Estimated Number of Responses per
Respondent: 4.
Average Burden Hours per Response:
Reduced by 156.
Estimated Total Annual Burden
Hours Requested: Reduced by 15,600.
The annualized cost to respondents is
estimated to be reduced by $780,000.
There are no Capital Costs to report.
There are no Operating or Maintenance
Costs to report.
Note: The following table is acceptable for
the Respondent and Burden Estimate
information, if appropriate, instead of the
text as shown above.
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 75, Number 160 (Thursday, August 19, 2010)]
[Notices]
[Pages 51271-51272]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-20482]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0420]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Testing Communications on the Food and Drug
Administration/Center for Veterinary Medicine's Regulated Products Used
in Animals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on communication studies involving FDA/Center
for Veterinary Medicine (CVM) regulated products intended for use in
animals. This information will be used to explore concepts of interest
and assist in the development and modification of communication
messages and campaigns to fulfill the Agency's mission in protecting
the public health.
DATES: Submit either electronic or written comments on the collection
of information by October 18, 2010.
ADDRESSES: Submit electronic comments on the collection of information
to https://www.regulations.gov. Submit written comments on the
collection of information to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket
number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
P150-400B, Rockville, MD 20850, 301-796-3793.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information before
submitting the collection to OMB for approval. To comply with this
requirement, FDA is publishing notice of the proposed collection of
information set forth in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.
Testing Communications on the Food and Drug Administration/Center for
Veterinary Medicine's Regulated Products Used in Animals--21 U.S.C. 393
(d)(2)(D)--(OMB Control Number-0910-NEW )
CVM has authorization under section 903(d)(2)(D) of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C. 393(d)(2)(D) to conduct
educational and public information programs relating to the safety of
CVM-regulated products. Further, CVM is authorized to conduct this
needed research to ensure that these programs have the highest
likelihood of being effective. Thus, CVM concludes that improving
communications about the safety of regulated animal drugs, feed, food
additives, and devices will involve many research methods, including
individual indepth interviews, mall-intercept interviews, focus groups,
self-administered surveys, gatekeeper reviews, and omnibus telephone
surveys.
The information collected will serve three major purposes. First,
as formative research, it will provide critical knowledge needed about
target audiences to develop messages and campaigns about the use of
animal drugs, feed, food additives, and devices. Knowledge of both the
consumer and the veterinary professional decisionmaking processes will
provide a better understanding of target audiences that FDA will need
in order to design effective communication strategies, messages, and
labels. These communications will aim to improve public understanding
of the risks and benefits of using regulated animal drugs, feed, food
additives, and devices by providing users with a better context in
which to place risk information more completely. Second, as initial
testing, it will allow FDA to assess the potential effectiveness of
messages and materials in reaching and successfully communicating with
their intended audiences. Testing messages with a sample of the target
audience will allow
[[Page 51272]]
FDA to refine messages while still in the developmental stage.
Respondents will be asked to give their reaction to the messages in
either individual or group settings. Third, as evaluative research, it
will allow FDA to ascertain the effectiveness of the messages and the
distribution method of these messages in achieving the objectives of
the message campaign. Evaluation of campaigns is a vital link in
continuous improvement of communications at FDA.
FDA estimates the burden of this collection of information as
follows:
Table 1.--Estimated Annual Reporting Burden\1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
No. of Annual Frequency Total Annual Hours per
21 U.S.C. 393(d)(2)(D) Respondents per Response Responses Response Total Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Individual indepth interviews 360 1 360 .75 270
--------------------------------------------------------------------------------------------------------------------------------------------------------
General public focus group interviews 144 1 144 1.5 216
--------------------------------------------------------------------------------------------------------------------------------------------------------
Intercept interviews: Central location 600 1 600 .25 150
--------------------------------------------------------------------------------------------------------------------------------------------------------
Intercept Interviews: Telephone\2\ 10,000 1 10,000 .08 800
--------------------------------------------------------------------------------------------------------------------------------------------------------
Self-administered surveys 2,400 1 2,400 .25 600
--------------------------------------------------------------------------------------------------------------------------------------------------------
Gatekeeper reviews 400 1 400 .50 200
--------------------------------------------------------------------------------------------------------------------------------------------------------
Omnibus surveys 2,400 1 2,400 .17 408
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total (general public) 2,644
-----------------------------------------------------------------------------------------------------------------------------------------
Total veterinarian/scientific expert focus group interviews 144 1 144 1.5 216
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total Burden 2,860
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
\2\ These are brief interviews with callers to test message concepts and strategies following their call-in request to an FDA Center 1-800 number.
FDA's estimate for the annual reporting burden of the proposed
collection of information requirements is based on recent prior
experience with the various types of data collection methods described
previously. FDA projects about 30 studies for which the annual
reporting burden is estimated to be 2,860 hours.
Dated: August 13, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-20482 Filed 8-18-10; 8:45 am]
BILLING CODE 4160-01-S
